Double-Headed Hydrate Inhibitors Prevent Pipeline Blockages
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Gas hydrates form in fluid flowing through pipelines during hydrocarbon production, leading to blockages that can stop production, pose safety risks, and are difficult to mediate, potentially causing environmental harm.
Innovation Solution
Development of hydrate inhibitor compounds with a lipophilic tail, two hydrophilic heads, and linking moieties that can be introduced into the fluid to inhibit the formation of gas hydrates by preventing agglomeration, characterized by their ability to attach to hydrate particles and disperse them, thereby reducing their size and preventing aggregation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional hydrate inhibitors are used, then hydrate formation is inhibited, but high dosage is required and cost is high
Solution Approach 1:
The patent applies composite materials by combining a lipophilic tail group with hydrophilic head groups containing multiple functional groups (carboxylic acid, amine, alcohol, or ether) in a single inhibitor molecule. This composite structure enables the molecule to simultaneously interact with both hydrate surfaces and water molecules, enhancing inhibition effectiveness per unit dosage and reducing the overall quantity of inhibitor needed.
Solution Approach 2:
The patent implements local quality by designing asymmetric molecular structures where different parts of the inhibitor molecule have specialized functions: the lipophilic tail anchors to the hydrate surface while the hydrophilic head with multiple functional groups interacts with water. This localized functional differentiation maximizes the inhibitor's effectiveness at specific interaction sites, improving performance without increasing dosage.
2Reliability
If conventional hydrate inhibitors are used, then hydrate agglomeration is prevented, but device complexity and treatment difficulty increase
Solution Approach 1:
The patent applies self-service by designing inhibitor molecules that automatically orient themselves at hydrate surfaces through their amphiphilic structure. The lipophilic tail spontaneously anchors to the hydrate while the hydrophilic head extends into the aqueous phase, creating steric and electrostatic barriers without requiring external control systems or complex injection equipment.
Solution Approach 2:
The patent implements parameter changes by modifying the molecular structure parameters of the inhibitor, specifically incorporating multiple functional groups with different polarities and bonding characteristics. This changes the chemical interaction parameters at the hydrate-water interface, enhancing anti-agglomeration performance through molecular design rather than system complexity.
3Productivity
If existing hydrate inhibitors are used, then flow maintenance is achieved, but safety risks and environmental harm persist
Solution Approach 1:
The patent applies this principle by using biodegradable natural products (fatty acids, amino acids, sugars, or their derivatives) as inhibitor molecules. These organic compounds serve their hydrate inhibition function and then naturally decompose, replacing persistent synthetic chemicals with short-lived, environmentally benign alternatives that maintain productivity without long-term environmental harm.
Solution Approach 2:
The patent implements parameter changes by transitioning from synthetic chemical inhibitors to natural product-based inhibitors, fundamentally changing the chemical composition parameters. This substitution maintains flow maintenance effectiveness while eliminating the harmful factors associated with toxic synthetic chemicals, addressing both productivity and environmental safety requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrate inhibitor compounds effectively inhibit the formation and agglomeration of hydrates, maintaining fluid flow and reducing the risk of blockages and safety hazards, with enhanced anti-agglomeration properties compared to existing methods, allowing for lower dosage usage.
Implementation Method 1
characterized by their ability to attach to hydrate particles and disperse them
Implementation Method 2
hydrate inhibitor compounds with a lipophilic tail, two hydrophilic heads, and linking moieties
Data Source
AI summary
Compositions and methods of using of such compositions to, for example, inhibit of the formation of gas hydrate agglomerates are provided. In one embodiment, the methods comprise: introducing a hydrate inhibitor composition comprising a compound into a fluid, wherein the compound comprises two hydrophobic cation moieties, a lipophilic tail, and two linking moieties.